The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial

被引:40
|
作者
Javadi, Leila [1 ]
Ghavami, Mostafa [2 ]
Khoshbaten, Manouchehr [3 ]
Safaiyan, Abdolrasoul [4 ]
Barzegari, Abolfazl [5 ]
Gargari, Bahram Pourghassem [6 ]
机构
[1] Tabriz Univ Med Sci, Nutr Res Ctr, Student Res Comm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Paramed, Tabriz, Iran
[3] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran
[4] Rd Traff Injury Res Ctr, Dept Biostat & Epidemiol, Tabriz, Iran
[5] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[6] Tabriz Univ Med Sci, Sch Nutr & Food Sci, Dept Biochem & Diet Therapy, Nutr Res Ctr, Tabriz, Iran
关键词
Probiotic; Prebiotic; Liver Function; Steatosis; NAFLD; GUT MICROBIOTA; INSULIN-RESISTANCE; OBESITY; STEATOHEPATITIS; AMINOTRANSFERASES; ENDOTOXEMIA; MECHANISM; DIAGNOSIS; NAFLD; MICE;
D O I
10.5812/ircmj.46017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Oral administration of pro-and prebiotics has recently been considered as an effective way for nonalcoholic fatty liver disease (NAFLD) recovery. Objectives: The current study aimed at evaluating the effect of supplementation with probiotics and/or prebiotics on liver function tests in patients with NAFLD. Methods: In this double blind, placebo-control clinical trial, 75 subjects with NAFLD were voluntarily recruited from May 2013 to March 2014, in Iran. Participants were randomly assigned to 1 of 4 groups using a block randomization procedure. Group 1 received probiotic capsules (Bifidobacterium longum (BL) and Lactobacillus acidophilus (LA): 2 x 10(7) CFU/day), group 2 received prebiotic inulin high performance (HP): 10 g/day, group 3 received probiotic and the prebiotic, and group 4 received a placebo for 3 months. The sample size was determined on the basis of a primary outcome of a change in aspartate aminotransferase (AST) level. Results: Anintergroup comparison indicated that the AST (P =0.006) and alanine aminotransferase (ALT) (P = 0.04) levels decreased at the end of the study. Aspartate Aminotransferase (mean difference of group1 versus placebo with P value of 0.001, group2 versus placebo with P value of 0.045, group3 versus placebo with P value of 0.015) and ALT (mean difference of group 1 versus placebo with P value of 0.009, group 2 versus placebo with P value of 0.041, and group 3 versus placebo with P value of 0.046) serum levels decreased significantly in all of the intervention groups compared to the placebo. The grade of fatty liver in group 1 (P of 0.027, and number needed to treat (NNT) = 3) and group 3 (P = 0.019 and NNT = 3) decreased compared to the placebo group with no significant changes in group 2. Conclusions: Supplementation with probiotics and/or prebiotics improved aminotransferase enzymes,and supplementation with probiotics or pro-and prebiotics recovered the grade of fatty liver in NAFLD patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial
    Aller, R.
    de Luis, D. A.
    Izaola, O.
    Conde, R.
    Gonzalez Sagrado, M.
    Primo, D.
    de la Fuente, B.
    Gonzalez, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2011, 15 (09) : 1090 - 1095
  • [2] Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial
    Atarodi, Named
    Pazouki, Abdolreza
    Gholizadeh, Barmak
    Karami, Reza
    Kabir, Ali
    Sadri, Ghazal
    Kassir, Radwan
    Kermansaravi, Mohammad
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2022, 27 (01): : 76
  • [3] The Effect of Pioglitazone and Metformin on Liver Function Tests, Insulin Resistance, and Liver Fat Content in Nonalcoholic Fatty Liver Disease: A Randomized Double Blinded Clinical Trial
    Razavizade, Mohsen
    Jamali, Raika
    Arj, Abbas
    Matini, Seyyed Mohammad
    Moraveji, Alireza
    Taherkhani, Effat
    HEPATITIS MONTHLY, 2013, 13 (05)
  • [4] Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial
    Behrouz, Vahideh
    Aryaeian, Naheed
    Zahedi, Mohammad Javad
    Jazayeri, Shima
    JOURNAL OF FOOD SCIENCE, 2020, 85 (10) : 3611 - 3617
  • [5] Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial
    Sepideh, Abbaszadeh
    Karim, Parastouei
    Hossein, Afshari
    Leila, Rostami
    Hamdollah, Mahmoudi
    Mohammad, Ghamarchehreh E.
    Mojtaba, Sepandi
    Mohammad, Samadi
    Ghader, Ghanizadeh
    Moayed, Alavian Seyed
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2016, 35 (06) : 500 - 505
  • [6] The Efficacy of Rosa damascena on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial
    Moravej, S. Ali Al-Hadi
    Shojaii, Asie
    Dabaghian, Fataneh Hashem
    Jazayeri, S. Ferdows
    Moravej, S. Zahra
    Khadem, Ebrahim
    Agah, Shahram
    Ghods, Roshanak
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [7] The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial
    Jarhahzadeh, Maryam
    Alavinejad, Pezhman
    Farsi, Farnaz
    Husain, Durdana
    Rezazadeh, Afshin
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [8] The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial
    Maryam jarhahzadeh
    Pezhman Alavinejad
    Farnaz Farsi
    Durdana Husain
    Afshin Rezazadeh
    Diabetology & Metabolic Syndrome, 13
  • [9] Effectiveness of prebiotic treatment in patients with nonalcoholic fatty liver disease (NAFLD)-a randomized trial
    Maor, Yaakov
    Reshef, Naama
    Gophna, Uri
    Konikoff, Fred
    Knobler, Hilla
    JOURNAL OF HEPATOLOGY, 2023, 78 : S824 - S825
  • [10] Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)-A Randomized Pilot Trial
    Reshef, Naama
    Gophna, Uri
    Reshef, Leah
    Konikoff, Fred
    Gabay, Gila
    Zornitzki, Taiba
    Knobler, Hilla
    Maor, Yaakov
    NUTRIENTS, 2024, 16 (11)